Hang Seng Indexes has launched four equity indices with focuses on biotech, large-mid cap equities with a momentum tilt and stocks that are eligible for Southbound Trading under the Stock Connect scheme.

The Hang Seng Hong Kong-Listed Biotech index is comprised of biotech companies listed in Hong Kong. They are classified as biotechnology, pharmaceuticals or medical devices under the Hang Seng industry classification system.

The Hang Seng Large-Mid Cap Momentum 50 index and the Hang Seng Large-Mid-Cap Momentum Tilt index use momentum factor strategies that aim to capture returns when high-momentum companies maintain high-price performances. The former includes the top 50 securities from the latter with the highest momentum factor scores.

Finally, the Hang Seng Stock Connect Hong Kong Composite index is a benchmark for monitoring the performance of all stocks that are eligible for the Southbound Trading under the Stock Connect scheme.

All four indices have a base-currency in Hong Kong dollar.

In the summer, Hang Seng launched an index comprised of securities that have Chinese government entities as their largest shareholder.